Groowe BETA / Newsroom

⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Niagen Bioscience Selects Global Drug Development Pioneer Evotec to Advance Preclinical Development for NB4168

businesswire.com August 3, 2026 at 7:32 AM ET

NAGE Niagen Bioscience has selected Evotec to advance preclinical development for NB4168. The article focuses on the partnership and development progress, without explicit positive or negative financial implications.